Embellence Group AB (publ) (EMBELL) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you very much, and welcome to Ambulance Group's Q2 report. My name is Johan Angen, and I'm the CEO of the group, and together with me today is Colin Lydian, who is the CFO. Let's start to look at the business and what we achieved in the second quarter of the year. During the quarter, we delivered increased sales and EBITDA, and we increased both our gross margin and our EBITDA margins. And we continued our journey towards our long-term financial goals and our focus on delivering profitable growth. The organic sales growth in the quarter was 4%, but it was negatively affected by exchange rates, with 3%. Hence, the overall group sales numbers came in at 193 million Swedish krona, plus 2 million Swedish krona versus past year. Exchange rates did have a negative impact on the business in Q2, and with the current trends, we expect that pressure continues in the coming quarters, which Colin will shed some more light on later on. We are continuing making progress towards our long-term EBITDA target of 15%, and in the quarter, the total group's EBITDA margin landed at 13.5%, up 0.5 percentage points versus past year. delivering an EBITDA of 26 million Swedish krona, up 1 million Swedish krona versus past year. Q2 is the quarter with larger marketing activities than thirds, such as Salona del Modena, which is why the EBITDA margin in the quarter is naturally lower in percentage than other quarters. The development is positive, and on a rolling 12-month period, our EBITDA margin increased to 14.6%, which is 0.7 percentage points up versus past year, and one step closer to our long-term targets. Our long-term strategy and focus to deliver profitable growth is paying off, and we continue to see gross margin improvements. The gross margin, in fact, came in at 61.9%, growing...